Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Precipio Inc (PRPO)

Precipio Inc (PRPO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Precipio Announces Q2-2026 Financial Results ACN Newswire - Mon Aug 17, 3:29PM CDT

Precipio Announces Q2-2026 Financial Results

PRPO : 27.85 (+12.80%)
Precipio Announces Q2-2026 Financial Results GlobeNewswire - Fri Aug 14, 3:00PM CDT

NEW HAVEN, Conn., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company  Precipio, Inc. (NASDAQ: PRPO) , announces financial results for the second quarter that ended June 30,...

PRPO : 27.85 (+12.80%)
Precipio Announces Q2-2026 Shareholder Update Call GlobeNewswire - Fri Jul 31, 3:00PM CDT

NEW HAVEN, Conn., July 31, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc.   (NASDAQ: PRPO) , will be hosting its Q2-2026 shareholder update call on August 17 th ,...

PRPO : 27.85 (+12.80%)
Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting GlobeNewswire - Fri Jun 12, 12:00PM CDT

NEW HAVEN, Conn., June 12, 2026 (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics company Precipio, Inc.   (NASDAQ: PRPO)  is requesting that shareholders instruct their brokers to...

PRPO : 27.85 (+12.80%)
Precipio to Present at the Planet MicroCap Las Vegas GlobeNewswire - Thu Jun 11, 4:00PM CDT

NEW HAVEN, Conn., June 11, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company  Precipio, Inc. (NASDAQ: PRPO) , announces that it will be presenting at the Planet MicroCap Las Vegas...

PRPO : 27.85 (+12.80%)
Precipio Announces Q1 2026 Financial Results GlobeNewswire - Thu May 14, 4:00PM CDT

NEW HAVEN, Conn., May 14, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announces financial results for the first quarter ended March 31, 2026....

PRPO : 27.85 (+12.80%)
Management team’s 2025 market-based Options have vested GlobeNewswire - Wed May 13, 4:00PM CDT

NEW HAVEN, Conn., May 13, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company  Precipio, Inc.   (NASDAQ: PRPO) announces that 2025 employee stock options granted to certain members of...

PRPO : 27.85 (+12.80%)
Precipio Announces Q1-2026 Shareholder Update Call GlobeNewswire - Wed May 6, 4:00PM CDT

NEW HAVEN, Conn., May 06, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc.   (NASDAQ: PRPO) , will be hosting its Q1-2026 shareholder update call on May 18 th , 2026,...

PRPO : 27.85 (+12.80%)
Precipio Announces Q4 and year-end 2025 Shareholder Update Call GlobeNewswire - Thu Mar 12, 4:00PM CDT

NEW HAVEN, Conn., March 12, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc.   (NASDAQ: PRPO) , will be hosting its Q4 and year end 2025 corporate update call on April 2...

PRPO : 27.85 (+12.80%)
Precipio Announces Publication of a Joint Study with Memorial Sloan-Kettering Cancer Center Highlighting Its Cutting-Edge Bloodhound BCR::ABL1 Assay GlobeNewswire - Tue Mar 10, 8:00AM CDT

NEW HAVEN, Conn., March 10, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc.   (NASDAQ: PRPO) has announced the publication 1 in the Journal of Clinical Pathology...

PRPO : 27.85 (+12.80%)

Barchart Exclusives

3 Next-Gen AI Stocks That 3G Capital Bought in Q2 Barchart - 23 minutes ago
As we move further into 2026, 3G Capital is making fresh Q2 bets on three stocks positioned to benefit from the accelerating AI infrastructure boom. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.